Lifecore Biomedical, Inc.LFCRNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank29
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P29
Within normal range
vs 3Y Ago
-0.2x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -3.70% |
| 2024 | -1.84% |
| 2023 | 11.44% |
| 2022 | 17.28% |
| 2021 | -11.84% |
| 2020 | -33.87% |
| 2019 | -10.42% |
| 2018 | 35.12% |
| 2017 | 31.06% |
| 2016 | 3.43% |